"Authorized" Generics Violate Predatory Pricing Laws, Mylan Lawsuit Says

Mylan alleges P&G and Watson violated Robinson-Patman and Sherman antitrust laws by selling an "authorized" generic of Macrobid below cost with the intent to monopolize the market. The lawsuit is aimed at preventing authorized generics during Mylan's 180-day exclusivity period for Norvasc, Levaquin and Ditropan XL.